Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-stage Studies
Summary by Medscape
1 Articles
1 Articles
All
Left
Center
Right
Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-stage Studies
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs... Reuters Health Information
·United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium